Interventional AnalgesiX Inc.
↗Durham, North Carolina, United States
Interventional AnalgesiX Inc. (IAX) is an early-stage biotech company headquartered in Durham, North Carolina, developing innovative non-addictive analgesics for chronic pain conditions. The company is pioneering two complementary therapeutic approaches: (1) adeno-associated virus (AAV) gene therapy for pain targeting dorsal root ganglia, leveraging over 25 years of published research; and (2) resiniferatoxin (RTX), a potent TRPV1 agonist that provides long-term pain relief through chemo-inactivation of nerve terminals. IAX has formulated a second-generation RTX product (CapRTX) using FDA-approved Captisol as a solubilizer, validated in large animal pain models. The company's research addresses major unmet needs in pain management for osteoarthritis, cancer pain, and other chronic pain conditions.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Pain Management / Therapeutic Gene Therapy
SIZE & FINANCIALS
Employees:1-50
Founded:2017
Ownership:private
Status:operating
FUNDING
Stage:Seed/Early Stage
PIPELINE
Stage:Preclinical
Lead Drug Stage:Preclinical / Early Development
Modalities:Gene Therapy (AAV), Small Molecule / Natural Product (Resiniferatoxin), TRPV1 Agonist
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:National Institutes of Health (NIH) - NINDS funding support, Mayo Clinic - Research collaboration and validation, UC San Diego - Academic research partnership
COMPETITION
Position:Emerging
Competitors:Vertex Pharmaceuticals (pain gene therapy), Biohaven Pharmaceuticals (pain therapeutics), Purdue Pharma (pain management), Other AAV gene therapy companies (Sesen Bio, Affinia Therapeutics)
LEADERSHIP
Key Executives:
Andreas S. Beutler, MD, PhD - Founder and Chief Executive Officer
Michaela Banck, MD - Chief Operating Officer
Scientific Founders:Andreas S. Beutler, MD, PhD - Founder (pain gene therapy pioneer)
LINKS
Website:iax.us
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Interventional AnalgesiX Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Interventional AnalgesiX Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.